Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
Aclarion announced publication of an independent, peer-reviewed study in the European Spine Journal validating Nociscan against invasive discography for identifying painful lumbar discs. Conducted at the London Spine Clinic across 20 patients and 55 discs, Nociscan agreed with discography in up to 87% of cases while avoiding needles, added cost, and recovery time — with Nociscan priced at roughly £2,040 versus £2,775 for a discogram.
Key figures
- Drug Name
- Nociscan
- Discogram cost
- £2,775
- Patients enrolled
- 20
- Nociscan exam cost
- £2,040
- Lumbar discs evaluated
- 55
- Discography agreement rate
- 87%
- Global low back pain patients
- 266 million
- Surgical success rate nociscan positive
- 97%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.